Although the function of DCAF13 has not yet been demonstrated, findings indicate that DCAF13 is associated with worse prognosis of breast cancer patients (Chin et al., 2007) and HCC patients (Cao et al., 2017), which is consistent with our finding. Here, DCAF13 is linked to hepatocellular carcinoma.